Penumbra market share. (NYSE: PEN) announced the U.

Penumbra market share. The fund owned 8,365 shares of the company's stock after acquiring an addit Nov 15, 2024 · In the neurovascular space, Penumbra maintains a dominant 35% market share, outpacing competitors like Stryker (25%) and Medtronic (20%). 995 billion. 14 billion by 2030. 10 Billion in 2032 registering a CAGR of 6. 81 B on February 19, 2025, which is 10. (PEN) stock news and headlines to help you in your trading and investing decisions. 55M by 2033, growing steadily at 4. 84 Billion As of August 2025 Penumbra has a market cap of £7. Jan 7, 2025 · Penumbra (PEN) stock rises as Stryker (SYK) agrees to acquire its rival in the thrombectomy market, Inari Medical (NARI) for $4. (NYSE:PEN - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. Morgan analysts. P. 030", it offers the largest primary diameter of any coil on the market. VTE market, with 42% year-over-year growth, demonstrates the company’s May 12, 2025 · A competitive analysis shows these companies are in the same general field as Penumbra, even though they may not compete head-to-head. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. On September 17, 2025, Penumbra, Inc. Get the latest Penumbra, Inc. Jun 15, 2023 · The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. 0% CAGR. Feb 19, 2025 · Penumbra targets 13%-14% revenue growth for 2025 with focus on thrombectomy market expansion Feb. (PEN) stock price, market cap, P/E ratio, revenue, earnings call summary, income statement, key executives, and financial performance on NASDAQ. It is regarded third in market capitalization category among related companies creating about 395,008,379 of Market Capitalization per Book Value Per Share. grew its position in Penumbra, Inc. Although there was a slight downtick in Inari’s market share from 2022 Q4, the company continues to dominate the 6 days ago · See the latest Penumbra Inc stock price (PEN:XNYS), related news, valuation, dividends and more to help you make your investing decisions. Presently, Penumbra boasts a market capitalization of $10. In Q1 2024, Penumbra reported $265. Track Penumbra's latest market cap ( PEN), now at $9. At . Market capitalization of Penumbra (PEN) Market cap: C$13. Europe emerged as the largest market for the global embolization coils market, with a 33% share of the market revenue in 2022. Penumbra (PEN) Q1 2025: U. 4 billion in 2022 and is estimated to account for USD 2. 07 Billion. Aug 29, 2025 · PEN | Complete Penumbra Inc. Investors use various methods to calculate intrinsic value and Track PENUMBRA, INC. A significant portion of Penumbra's shares, 88. 0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. 5% in the prediction period and it crosses USD 5. 4 percent. 5 billion by 2032 owing to increasing incidence of neurovascular diseases. 36% change year over year. Nov 22, 2021 · Qsight reviews Penumbra's RED 72 catheter impact and how the company is recovering market share in stroke care post-recall. Compare Revenue and Market Capitalization for Penumbra using fundamental analysis. Market capitalization represents total company value in stock market; higher suggests larger, more established company. Discover the geographical origin of the shareholders of Penumbra, Inc. Aug 29, 2025 · In depth view into Penumbra Market Cap including historical data from 2015, charts and stats. Jun 5, 2025 · Insights Medical Device Specialist positive Penumbra's FDA-cleared Ruby XL System brings advanced coil technology that could increase procedure efficiency and capture market share in vascular embolization. Common Stock (PEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. 06 Billion. Our report provides a comprehensive overview of the industry, including key players, market share, growth opportunities, and more. (PEN) stock, including annual, quarterly and daily history with a chart and statistics. The XL System is the latest addition to the Ruby® Embolization Platform. Aug 19, 2025 · PEN | Complete Penumbra Inc. Explore more! Feb 18, 2025 · Webcast and Conference Call Information Penumbra, Inc. This makes Penumbra the world's 1969th most valuable company by market cap according to our data. The global stent retriever industry is growing thanks to strong demand in a well-established sector, which increases revenue and encourages R&D investment. MD cut its position in shares of Penumbra, Inc. 06 Billion As of August 2025 Penumbra has a market cap of C$13. 08B. 29. Penumbra reported last year Book Value per Share of 16. 00, which is 21% above the current share price. Find contact information for Penumbra. Market capitalization of Penumbra (PEN) Market cap: £7. The firm owned 1,208,431 shares of the company's stock after se Sep 6, 2025 · Raymond James Financial Inc. 1 day ago · What opportunities does Penumbra have for market share gains in key segments? Penumbra’s strong performance in the U. 00, indicating a potential upside of 9. 96%, and its shares gained 27. 52-week low Oct 16, 2024 · Moreover, despite concerns about the sustainability of growth in a competitive market, the recent advancements in their CAVT technology and market share gains in Arterial and VTE segments provide Sep 10, 2025 · Polar Asset Management Partners Inc. 37 Billion, at a 9. Penumbra Book Value per Share is very stable at the moment as compared to the past year. Penumbra's marketing mix includes peripheral vascular devices, addressing diseases like deep vein thrombosis. According to Penumbra, the Ruby XL, which features a long, large, and soft coil, is designed to help physicians achieve more Historical daily share price chart and data for Penumbra since 2015 adjusted for splits and dividends. Read more here. PEN reduced guidance after Q2 earnings, but the market took it in stride Dec 17, 2024 · Oppenheimer predicts growth for Penumbra Inc in MT market. Total visits to Penumbra's top domains Understand Penumbra market share and potential market reach. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. 7% from 2021 to 2028 segmented into Type, Material, Application, and End User. “New products should drive share capture across both arterial and We would like to show you a description here but the site won’t allow us. 76 of Current Valuation per Market Capitalization. listed on the Nyse stock exchange. A high-level overview of Penumbra, Inc. 4 days ago · Should You Buy or Sell Penumbra Stock? Get The Latest PEN Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. 29 per share, with a market capitalization of $9. Track current and historical market cap trends with AI-powered fundamental data and custom analysis. 3% CAGR from 2023 to 2032, driven by the increasing prevalence of cardiovascular disorders and the surging need for effective treatment procedures worldwide. Aug 4, 2025 · Market players such as Stryker, Medtronic, Terumo Corporation, and Penumbra Inc. The institutional investor owned 40,259 shares of the company's stock PEN - Penumbra Inc - Stock screener for investors and traders, financial visualizations. 84 Billion. accounted for a major portion of the market share in 2024. stock was issued. 31. 4% year-over-year. 62% of their value over the last 52 weeks. Jun 20, 2025 · The new system is expected to enable Penumbra to increase its market share in peripheral embolization coils, according to GlobalData. 09 Billion. Explore insights on market size, innovations, and key industry players. , Aug. Sep 15, 2025 · Belpointe Asset Management LLC acquired a new position in shares of Penumbra, Inc. 70 B on April 16, 2025, a 32. (PEN) is a leader in medical technology. (PEN) stock. Based on total revenues. Market Capitalization is USD 10. 5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. Jun 8, 2023 · Dive Brief: Penumbra is expected to retain and take market share in the peripheral vascular market over the next 6 to 18 months, according to a survey of physicians by J. 3 days ago · Current and historical market capitalization for Penumbra, Inc. announced the FDA clearance and launch of the Ruby XL system, part of the company’s Ruby portfolio of peripheral embolization products. Europe dominated the peripheral embolization coils market in 2023. 18, 2025 11:05 PM ET Penumbra, Inc. However, if Feb 18, 2025 · Penumbra announced their Q4 2024 earnings on 2/18/2025. This makes Penumbra the world's 1817th most valuable company by market cap according to our data. 06 on June 30, 2023. The latest closing stock price for Penumbra as of September 17, 2025 is 256. US Embolization Coils Market was valued at US$ 388. This makes Penumbra the world's 1825th most valuable company by market cap according to our data. (NYSE:PEN) stock closed at $256. Discover its mission, history, and how it generates revenue in the healthcare industry. The two types of devices are Stent Retrievers and Aspiration Catheters. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure PENumbra, Inc. (NYSE:PEN - Free Report) by 38. The company's income from operations decreased 87% due to $115 million in exit-related charges. The thrombectomy devices market size was worth USD 1. These are the largest companies by revenue. 30% to reach USD 1. It is rated top company in current valuation category among related companies reporting about 0. Jun 9, 2025 · Henceforth, we expect the latest launch to maintain a positive market sentiment toward PEN stock in the upcoming days. The versatility of the Ruby XL system allows for a broader range of aneurysm sizes to be addressed, potentially attracting more physicians to choose Penumbra’s coils for their procedures. The neurovascular embolization market size was valued at USD 1. Acandis GmbH, Stryker, Penumbra, Inc. Penumbra is considered to be number one stock in market capitalization category among related companies. The focus on innovation and market Stock InformationHistorical Stock Quote Email Alerts Contact Us Penumbra, Inc. Penumbra Market Capitalization is quite stable at the moment as compared to the past year. 9B in cash. (NYSE:PEN - Free Report) by 33. Discover the latest trends and analysis on the Neurovascular Devices Market. 88%, is owned by institutional investors Neuroendovascular Coil market to rise from USD 1091. The latest Penumbra stock prices, stock quotes, news, and PEN history to help you invest and trade smarter. Analysts expect Penumbra to post earnings of $0. 07 Billion As of September 2025 Penumbra has a market cap of €9. 08B as of Jul 16, 2025. Use our SWOT analysis template to map Penumbra's market fit! Understand internal/external factors. 59 Billion by 2028, with a high CAGR for the forecast period. The ratio of Market Capitalization to Current Valuation for Penumbra is roughly 1. 03 billion. 2461 Sep 16, 2025 · Penumbra is a global healthcare company that is focused on innovating novel technologies to help as many people as possible. Specific areas of growth for its products going forward are deep-vein thrombosis and pulmonary embolism. Understand how these financial metrics relate to long-term value. 5% during the first quarter, according to its most recent 13F filing with the SEC. Headquarters One Penumbra Place Alameda, CA 94502 USA [email protected] [email protected] 1. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure Aug 2, 2025 · Okay, I will conduct a Boston Consulting Group (BCG) Growth-Share Matrix analysis for Penumbra Inc, adhering to the specified structure, tone, and data requirements. Market capitalization of Penumbra (PEN) Market cap: €9. , headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. 995. 34% above the current Market Capitalization. Investors use various methods to calculate intrinsic value and Blood Clot Retrieval Devices Market Size, Share, Growth Analysis Report By Stroke (Ischemic Stroke (Blood Clot), Hemorrhagic Stroke (Rupturing of Arteries) and Transient Ischemic Attack), By Device (Mechanical Embolus Removal Devices, Penumbra Blood Clot Retrieval Devices, Stent Retrievers, Aspiration Devices, and Ultrasound Assisted Devices), Application (Coronary Arteries, Peripheral Sep 10, 2025 · Travis Steed has given his Buy rating due to a combination of factors surrounding Penumbra’s new Ruby XL product. 87 Bn in 2025. 510. with information on the company's activities, financials, digital presence, market capitalization, stocks and stock indices, … The global vascular embolization market size was valued at US$ 3,016 million in 2024 and is poised to grow at an 9. Jul 12, 2025 · Aggressive pricing and technological advancements from competitors could impact Penumbra's market share. The firm surveyed 25 vascular surgeons, who forecast that Penumbra will take share as the broader peripheral market is expected to grow. Aug 20, 2024 · Read here for an analysis of Penumbra's stock performance and market trends, including revenue growth, competition, and potential future share price projections. 82 billion in 2025 and grow at a CAGR of 6. 13 billion by 2032 from USD 1. Aug 20, 2024 · Summary Penumbra is continuing to take share with its new CAVT devices against its closest competition in the VTE space. Jun 20, 2025 · "Penumbra may gain market share in peripheral embolisation coils with Ruby XL" was originally created and published by Medical Device Network, a GlobalData owned brand. Sep 6, 2025 · Jump Financial LLC acquired a new stake in Penumbra, Inc. We would like to show you a description here but the site won’t allow us. (NYSE:PEN - Free Report) by 30. Food and Drug Administration (FDA) clearance and launch of the Ruby ® XL System, the longest, largest and softest coil on the market i. The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Jun 20, 2025 · Penumbra may gain market share in peripheral embolisation coils with Ruby XL All Ruby XL system coils can be delivered through a 0. View real-time stock prices and stock quotes for a full financial overview. Blood Clot Retrieval Devices Market Size, Trends and Insights By Stroke Type (Ischemic Stroke (blood clot), Hemorrhagic Stroke (rupturing of arteries), Transient Ischemic Attack), By Device Type (Mechanical Embolus Removal Devices, Penumbra Blood Clot Retrieval Devices, Stent Retrievers, Ultrasound Assisted Devices), By End Use (Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Aug 5, 2025 · Penumbra disclaims any duty to update or revise our forward-looking statements as a result of new information, future events, developments, or otherwise. The global Neurovascular Devices market size is expected to reach USD 5. Comparative valuation analysis is a catch-all model that Jul 1, 2025 · Company Profile of Penumbra, Inc. Morgan analysts [1], Penumbra is expected to retain and capture market share in the peripheral vascular market over the next 6 to 18 months. The strong presence of these companies is due to their focus on launching technologically advanced medical devices to strengthen its neurovascular product portfolio. (NYSE: PEN), the world’s leading thrombectomy company, today announced that its Board of Directors approved on August 5, 2024 a share repurchase authorization in the amount of up to $200 million, allowing Penumbra to repurchase its common stock from time to time at such prices as it deems appropriate through open market purchases, block Jun 5, 2025 · ALAMEDA, Calif. The company's current value of The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Read more on PEN stock here. Penumbra fundamental comparison: Market Capitalization vs Z ScoreThe market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how Jun 10, 2023 · Dive Brief Penumbra is expected to retain and take market share in the peripheral vascular market over the next 6 to 18 months, according to a survey of physicians by J. Investors use various methods to calculate intrinsic value and Penumbra Market Capitalization is currently at 5 B. This makes Penumbra the world's 1930th most valuable company by market cap according to our data. After attending the annual Pulmonary Embolism Symposium last week in Austin, Texas, the analysts predicted clinical guidelines could shift toward catheter-based therapy once data from ongoing Feb 26, 2025 · Blood Clot Retrieval Devices Market is growing with a CAGR of 15. This makes Penumbra the world's 1824th most valuable company by market cap according to our data. View daily, weekly or monthly format back to when Penumbra, Inc. PEN stock quote prices, financial information, real-time forecasts, and company news from CNN. . Penumbra market cap as of July 17, 2025 is $9. According to a recent survey by J. 61 million in 2021 and is projected to reach US$ 532. How much is Penumbra stock worth today? (NYSE: PEN) Penumbra currently has 38,999,129 outstanding shares. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value Discover the latest trends and growth analysis in the Stent Retriever Market. The institutional investor owned 34,850 shares of the company's stock after buying an additional 9,687 shares during the Discover historical prices for PEN stock on Yahoo Finance. Stent Retriever Market Regional Insights North America led the global Stent Retriever market with the highest market share of 60% in 2024. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. Sep 15, 2025 · Latest Penumbra Inc (PEN:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Jul 5, 2021 · Delveinsight estimates that the Neurovascular thrombectomy devices market size calculated for across 7MM by device type results in the maximum market share captured by the combinational procedure type devices (comprising of SOLONDRA and Solumbra), followed by stent retrievers and lastly, the aspiration catheters, in the year 2026. Penumbra stock was originally listed at a price of $41. The Penumbra 52-week low stock price is 185. Understanding the Penumbra competitive landscape is crucial for assessing its long-term growth potential. 5 days ago · A detailed overview of Penumbra, Inc. 035-inch diagnostic catheter. (PEN) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Jul 2, 2025 · Marketing & Branding Analysis of Penumbra Inc helps to evaluate brand portfolio alignment, identify hidden synergies, brand equity maximization, seamless customer experiences, and optimize marketing strategies across business units. 2 days ago · Diversified Trust Co grew its holdings in shares of Penumbra, Inc. 3% CAGR to reach The stroke Management Market surpassed USD 37 billion in 2022 and is poised to grow at 6% CAGR from 2023 to 2032 supported by technological advancements in the field of stroke management to better patient care. , a leading medical device company specializing in innovative thrombectomy and embolization products, has released its 2024 10-K report. (PEN), a leading medical device company, is poised for growth, fueled by strategic initiatives and market expansion. Pennumbra recently reported an earnings per share of $0. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how Embolization Coils Market expansion is likely to reach US$ 1. It is one of many ways to value Penumbra and is calculated by multiplying the price of the stock by the number of shares issued. (NYSE:PEN - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. Sep 16, 2025 · Is Penumbra (NYSE:PEN) the best stock in the MED INSTRUMENTS industry? Compare top PEN competitors at MarketBeat. 52-week high Market Capitalization is USD 11. Stay ahead with Nasdaq. 91%. 33M in 2025 to USD 1493. Analyst expectations for Penumbra’s trajectory over the next few years call for annualized EPS growth of 29. 08 Jun 5, 2025 · June 5, 2025—Penumbra, Inc. Investors use various methods to calculate intrinsic value and . (PEN) stock quote, history, news and other vital information to help you with your stock trading and investing. Other institutional investors and hedge fu Investors - Penumbra, Inc. Feb 18, 2025 · Penumbra Inc. lessened its stake in Penumbra, Inc. 3 million in revenue, with vascular products contributing significantly. 24 million by 2028 with a CAGR of 4. Penumbra Inc's competitive profile, comparisons of quarterly results to its competitors, by sales, income, profitability, market share by products and services - CSIMarket Penumbra is regarded fourth in book value per share category among related companies. 3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. 30 in Sep 18, 2015. Jul 16, 2025 · The market cap of Penumbra (PEN) is $9. Discover real-time Penumbra, Inc. (PEN) Stock AI-Generated Earnings Calls Insights Jul 12, 2025 · Discover the target market for Penumbra's medical devices. The Ruby XL System is designed to help physicians achieve more efficient embolization, potentially reducing radiation exposure, and optimizing outcomes – especially 5 days ago · The one-month return of Penumbra, Inc. The Indigo System, a thrombectomy device, is a key offering. 8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. Jul 22, 2025 · Penumbra (NYSE:PEN - Get Free Report) is expected to post its Q2 2025 quarterly earnings results after the market closes on Tuesday, July 29th. View (PEN) real-time stock price, chart, news, analysis, analyst reviews and more. The all-time high Penumbra stock closing price was 344. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. Penumbra, Inc. The report provides a comprehensive overview of the company's financial performance, business operations, strategic initiatives, and the challenges i… In 2023, GlobalData’s Market Model methodology determined that the leading player in the neurovascular thrombectomy devices market in the US was Medtronic followed by Stryker, Penumbra, Cerenovus, MicroVention, Imperative Care, Rapid Medical, Phenox and Balt. stock news by MarketWatch. However, the presence of smaller, innovative companies like Penumbra has led to fragmentation and increased competition in specific sub-segments. 09 Billion As of August 2025 Penumbra has a market cap of ₹821. Penumbra is considered to be number one stock in shares outstanding category among related companies. The fund owned 15,076 shares of the company's stock after acquiring an additional Jul 2, 2025 · The Global Neurovascular Thrombectomy Devices Market is expected to reach USD 0. The firm acquired 1,098 shares of the company's stock, valued at approximately $294,000. (NYSE:PEN - Free Report) by 4. Find the latest Penumbra, Inc. Aug 14, 2020 · Plovanic sees Inari and Penumbra gaining market share from Boston Scientific and from a bevy of smaller firms that deliver drugs through catheter-directed thrombolysis to treat clots. 8% CAGR from 2025 to 2031. Find out all the key statistics for Penumbra, Inc. 97B. Penumbra market cap history and chart from 2014 to 2025. Detailed statistics for Penumbra, Inc. 0%. 60 per share, the total value of Penumbra stock (market capitalization) is $9. Learn how the company focuses on healthcare providers and specialists in neurovascular care. As Penumbra builds its market share, it will be able to take even greater advantage of the market tailwinds outlined above. Get your Word/Excel bundle now! Penumbra, Inc. (PEN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Blood Clot Retrieval Devices Market Size, Share, & Growth Report By Stroke Type (Ischemic Stroke (Blood Clot), Hemorrhagic Stroke (Rupturing of Arteries), Transient Ischemic Attack), By Device Type (Mechanical Embolus Removal Devices, Penumbra Blood Clot Retrieval Devices, Stent Retrievers, Ultrasound Assisted Devices), By End Use (Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Sep 6, 2025 · PDT Partners LLC grew its stake in shares of Penumbra, Inc. Mar 17, 2025 · New data from the ongoing STRIKE-PE and STRIDE studies will be presented at the Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 29th through April 2nd in Nashville, Tennessee. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products. Sep 11, 2025 · View Penumbra, Inc. , June 5, 2025 /PRNewswire/ — Penumbra, Inc. Penumbra's FDA clearance for the Ruby® XL System represents a significant advancement in embolization technology. The product’s introduction is expected to significantly increase Penumbra’s market share in the coil and plug segment, as it offers advantages in terms of fewer coils needed and faster procedure times. (NYSE: PEN) announced the U. 90% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 to 2034 Aug 13, 2024 · ALAMEDA, Calif. Thrombectomy Grows 25% as CAVT Drives Market Share Gains April 23, 2025 | By EarningsIQ Research Penumbra’s first quarter Feb 18, 2025 · Penumbra's 2024 earnings were impacted by a significant exit from Immersive Healthcare, overshadowing a 20% surge in thrombectomy revenue and stagnation in embolization and access products. With products such as the Penumbra System and FlowTriever System, both Penumbra (NYSE: PEN) and Inari (NARI) operate in the market for thrombectomy devices, expected to grow at ~7. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth. Sep 7, 2025 · Key Points Evercore ISI has initiated coverage of Penumbra (NYSE:PEN) with an outperform rating and a price target of $300. According to industry reports, Stryker holds the largest market share in the global neurovascular intervention market, followed by Medtronic and Penumbra. The market is projected to grow, providing an opportunity for Penumbra to expand its Penumbra, Inc. 97 B, ranking #2060 globally. Aug 29, 2025 · Price T Rowe Associates Inc. Get insights on stock performance, financial trends, and industry impact. S. 3 days ago · Find the distribution by types of shareholders of Penumbra, Inc. (PEN) stock, including real-time price, chart, key statistics, news, and more. Trends and drivers in briefly analyzed Jun 23, 2025 · The new system is expected to enable Penumbra to increase its market share in peripheral embolisation coils, according to GlobalData. Vascular Embolization Market growth is projected to reach USD 5. 34 of Market Capitalization per Shares Outstanding. Penumbra Inc: Competitors Discover information and data insights on Penumbra Inc's key competitors and market peers. The institutional investor acquired 2,736 shares of the company's stock, valued at With thrombectomy procedures gaining fast popularity globally, Penumbra has been witnessing market share gains, banking on strong customer uptake of its Lightning Bolt and Flash lines. This segment's growth highlights its importance to the company's strategy. The Penumbra 52-week high stock price is 310. Aug 27, 2025 · Penumbra Inc's Q2 2025 quarter and 12 months market share, relative to the PEN's competitors. 37 million for the quarter. Europe currently dominates the embolization coils market with a 33% market revenue share in 2022. Learn about their Medical Devices & Equipment, Manufacturing market share, competitors, and Penumbra's email format. Mar 13, 2025 · Penumbra's thrombectomy growth and new products show promise, but high valuation at 7x 2025 revenue tempers appeal for GARP investors. 86, surpassing analysts' estimates, while revenue increased by 13. Get the latest Penumbra Inc (PEN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. (NYSE:PEN - Free Report) by 67. Peripheral Embolization Coils Market Share Analysis by Geography The geographic scope of the peripheral embolization coils market report encompasses five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. The latest interim results of these multi-centered, prospective studies continue to build further evidence to support the benefits of computer assisted vacuum thrombectomy (CAVT Find the latest Penumbra, Inc. Sep 2, 2025 · Market Share Concentration: Market share is moderately concentrated, with a few major players holding a significant portion of the market. 4 billion in 2022 and is estimated to expand significantly at 7. Penumbra (NYSE:PEN - Get Free Report) last 5 days ago · On September 17, 2025, Penumbra, Inc. Analyst initiates coverage with Outperform rating and $275 target price. Market Capitalization is the total market value of Penumbra's equity. 81 per share and revenue of $327. The company's Penumbra System for stroke treatment continues to be the gold standard, with a recent win in securing a multi-year contract with the largest hospital network in the Northeastern United States. Market capitalization of Penumbra (PEN) Market cap: ₹821. will host a conference call to discuss financial results for the fourth quarter and year ended December 31, 2024 after market close on Tuesday, February 18, 2025 at 4:30 PM Eastern Time. It is considered to be number one stock in market capitalization category among related companies creating about 126. Jun 21, 2025 · Currently, Penumbra holds a significant portion of the market share for these coils, as reflected in GlobalData’s US healthcare facility invoicing database. 13, 2024 — Penumbra, Inc. With Penumbra stock trading at $255. View PEN's earnings results, press release, and conference call transcript at MarketBeat. According to GlobalData’s US Healthcare Facility Invoicing Database, Penumbra currently holds the majority market share for peripheral embolisation coils. (PEN) stock, including valuation metrics, financial numbers, share information and more. Sep 26, 2023 · Dive Brief: Catheter-based interventions developed by Boston Scientific, Inari Medical and Penumbra could transform the treatment of pulmonary embolism in the coming years, according to BTIG analysts. (NYSE:PEN) was 1. , Medtronic and VESALIO, LLC are the major companies operating in this market. brkbkcf fbz bsyszje ofsle vkurh oxoby eoiy zzzey nvasj ckx